A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash
Clinical trial NCT04697069 · TERMINATED
Trial details
- NCT number
- NCT04697069
- Sponsor
- Vanda Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-04
- Primary completion
- 2021-12-13
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.